LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 332 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 2.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $40,935,000 | -32.0% | 325,627 | -26.6% | 0.05% | -40.7% |
| Q4 2018 | $60,171,000 | -40.6% | 443,412 | +20.1% | 0.09% | -27.1% |
| Q3 2018 | $101,311,000 | +52.1% | 369,086 | +14.8% | 0.12% | +49.4% |
| Q2 2018 | $66,601,000 | +36.7% | 321,475 | +9.0% | 0.08% | +29.5% |
| Q1 2018 | $48,705,000 | +40.6% | 294,899 | +16.6% | 0.06% | +45.2% |
| Q4 2017 | $34,638,000 | +75.0% | 252,961 | +74.0% | 0.04% | +75.0% |
| Q3 2017 | $19,794,000 | +53.1% | 145,381 | +36.6% | 0.02% | +50.0% |
| Q2 2017 | $12,925,000 | +31.1% | 106,462 | +14.3% | 0.02% | +33.3% |
| Q1 2017 | $9,862,000 | -17.7% | 93,183 | -21.0% | 0.01% | -20.0% |
| Q4 2016 | $11,985,000 | -36.0% | 117,948 | -35.7% | 0.02% | -34.8% |
| Q3 2016 | $18,718,000 | – | 183,406 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |